The Community Guide

- gsearch

Search Results

Narrow Results:

2024 1
2023 2
2014 1

Haiti 1
Japan 2

Journal Article 4

Dispatch 3

1 - 4 of 4 Results

Refine Results

Refine Results:

Hospital-Associated Outbreak of Middle East Respiratory Syndrome Coronavirus: A Serologic, Epidemiologic, and Clinical Description

CITE Title : Hospital-Associated Outbreak of Middle East Respiratory Syndrome Coronavirus: A Serologic, Epidemiologic, and Clinical Description Personal Author(s) : Al-Abdallat, Mohammad Mousa;Payne, Daniel C.;Alqasrawi, Sultan;Rha, Brian;Tohme, Rania A.;Abedi, Glen R.;Nsour, Mohannad Al;Iblan, Ibrahim;Jarour, Najwa;Farag, Noha H.;Haddadin, Aktham;Al-Sanouri, Tarek;Tamin, Azaibi;Harcourt, Jennifer L.;Kuhar, David T.;Swerdlow, David L.;Erdman, Dean D.;Pallansch, Mark A.;Haynes, Lia M.;Gerber, Susan I.; Published Date : 11 01 2014;11-1-; Source : Clin Infect Dis. 59(9):1225-1233 URL : https://stacks.cdc.gov/view/cdc/38974 Al-Abdallat, Mohammad Mousa et al. (2014). Hospital-Associated Outbreak of Middle East Respiratory Syndrome Coronavirus: A Serologic, Epidemiologic, and Clinical Description. 59(9). Al-Abdallat, Mohammad Mousa et al. "Hospital-Associated Outbreak of Middle East Respiratory Syndrome Coronavirus: A Serologic, Epidemiologic, and Clinical Description" 59, no. 9 (2014) Al-Abdallat, Mohammad Mousa et al. "Hospital-Associated Outbreak of Middle East Respiratory Syndrome Coronavirus: A Serologic, Epidemiologic, and Clinical Description" vol. 59, no. 9, 2014 Export RIS Citation Information.

:

Al-Abdallat, Mohammad Mousa ;

Payne, Daniel C.

11 01 2014 | Clin Infect Dis. 59(9):1225-1233

:

BackgroundIn April 2012, the Jordan Ministry of Health investigated an outbreak of lower respiratory illnesses at a hospital in Jordan; 2 fatal cases ...
Seroprevalence of Vibrio cholerae in Adults, Haiti, 2017

CITE Title : Seroprevalence of Vibrio cholerae in Adults, Haiti, 2017 Personal Author(s) : Matias, Wilfredo R.;Guillaume, Yodeline;Augustin, Gertrude Cene;Vissieres, Kenia;Ternier, Ralph;Charles, Richelle C.;Harris, Jason B.;Franke, Molly F.;Ivers, Louise C.; Published Date : 9 2023 Source : Emerg Infect Dis. 2023; 29(9):1929-1932 URL : https://stacks.cdc.gov/view/cdc/133585 Matias, Wilfredo R. et al. (2023). Seroprevalence of Vibrio cholerae in Adults, Haiti, 2017. 29(9). Matias, Wilfredo R. et al. "Seroprevalence of Vibrio cholerae in Adults, Haiti, 2017" 29, no. 9 (2023) Matias, Wilfredo R. et al. "Seroprevalence of Vibrio cholerae in Adults, Haiti, 2017" vol. 29, no. 9, 2023 Export RIS Citation Information.

:

Matias, Wilfredo R. ;

Guillaume, Yodeline

9 2023 | Emerg Infect Dis. 2023; 29(9):1929-1932

:

In Haiti in 2017, the prevalence of serum vibriocidal antibody titers against Vibrio cholerae serogroup O1 among adults was 12.4% in Cerca-la-Source a...
Infection-Induced SARS-CoV-2 Seroprevalence among Blood Donors, Japan, 2022

CITE Title : Infection-Induced SARS-CoV-2 Seroprevalence among Blood Donors, Japan, 2022 Personal Author(s) : Kinoshita, Ryo;Arashiro, Takeshi;Kitamura, Noriko;Arai, Satoru;Takahashi, Koki;Suzuki, Tadaki;Suzuki, Motoi;Yoneoka, Daisuke; Published Date : 9 2023 Source : Emerg Infect Dis. 2023; 29(9):1868-1871 URL : https://stacks.cdc.gov/view/cdc/133580 Kinoshita, Ryo et al. (2023). Infection-Induced SARS-CoV-2 Seroprevalence among Blood Donors, Japan, 2022. 29(9). Kinoshita, Ryo et al. "Infection-Induced SARS-CoV-2 Seroprevalence among Blood Donors, Japan, 2022" 29, no. 9 (2023) Kinoshita, Ryo et al. "Infection-Induced SARS-CoV-2 Seroprevalence among Blood Donors, Japan, 2022" vol. 29, no. 9, 2023 Export RIS Citation Information.

:

Kinoshita, Ryo ;

Arashiro, Takeshi

9 2023 | Emerg Infect Dis. 2023; 29(9):1868-1871

:

A nationwide survey of SARS-CoV-2 antinucleocapsid seroprevalence among blood donors in Japan revealed that, as of November 2022, infection-induced se...
Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence, Japan, 2023

CITE Title : Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence, Japan, 2023 Personal Author(s) : Kinoshita, Ryo;Miyamoto, Sho;Sakuraba, Shoko;Sugihara, Jun;Suzuki, Motoi;Suzuki, Tadaki;Yoneoka, Daisuke; Published Date : 6 2024 Source : Emerg Infect Dis. 2024; 30(6):1267-1270 URL : https://stacks.cdc.gov/view/cdc/156981 Kinoshita, Ryo et al. (2024). Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence, Japan, 2023. 30(6). Kinoshita, Ryo et al. "Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence, Japan, 2023" 30, no. 6 (2024) Kinoshita, Ryo et al. "Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence, Japan, 2023" vol. 30, no. 6, 2024 Export RIS Citation Information.

:

Kinoshita, Ryo ;

Miyamoto, Sho

6 2024 | Emerg Infect Dis. 2024; 30(6):1267-1270

:

We assessed SARS-CoV-2 seroprevalence in Japan during July-August 2023, with a focus on 2 key age groups, 0-15 and >80 years. We estimated overall ser...